Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Cancer Chemotherapy and Pharmacology|October 12, 2012
Pharmacokinetic study of omacetaxine mepesuccinate administered subcutaneously to patients with advanced solid and hematologic tumorsJohn Nemunaitis, Alain Mita, Joe Stephenson, et al.
Journal of Clinical Pharmacology|October 22, 2004
Population pharmacokinetics of clofarabine, a second-generation nucleoside analog, in pediatric patients with acute leukemiaPeter L Bonate, Adam Craig, Paul Gaynon, et al.
Emerging Infectious Diseases|March 10, 2022
Mathematical Modeling for Removing Border Entry and Quarantine Requirements for COVID-19, VanuatuCaroline van Gemert, Len Tarivonda, Posikai Samuel Tapo, et al.
ACS Photonics|March 9, 2026
A Study of the Avalanche Multiplication and Excess Noise in Al <sub><i>x</i></sub> In<sub>1-<i>x</i></sub> As<sub>γ</sub>Sb<sub>1‑</sub> <sub>γ</sub> Avalanche Photodiodes Lattice-Matched to GaSbXiao Jin, Wenguang Zhou, Yang Zhao, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 22, 2013
Subcutaneous omacetaxine mepesuccinate in patients with chronic-phase chronic myeloid leukemia previously treated with 2 or more tyrosine kinase inhibitors including imatinibJorge E Cortes, Franck E Nicolini, Meir Wetzler, et al.
Plos Genetics|January 6, 2017
BTB-BACK Domain Protein POB1 Suppresses Immune Cell Death by Targeting Ubiquitin E3 ligase PUB17 for DegradationBeatriz Orosa, Qin He, Joelle Mesmar, et al.
Blood|June 7, 2003
Phase 2 clinical and pharmacologic study of clofarabine in patients with refractory or relapsed acute leukemiaHagop Kantarjian, Varsha Gandhi, Jorge Cortes, et al.
JAMA Network Open|December 5, 2022
Efficacy and Safety of Pacritinib vs Placebo for Patients With Severe COVID-19: A Phase 2 Randomized Clinical TrialJohn Cafardi, Carole Miller, Howard Terebelo, et al.
Drug and Alcohol Review|September 16, 2025
Assessing the Early Impact of the Change in the Kava Importation Policy in AustraliaWinifred Asare-Doku, Amy Peacock, Stella Settumba, et al.
Haematologica|July 22, 2017
Vosaroxin in combination with decitabine in newly diagnosed older patients with acute myeloid leukemia or high-risk myelodysplastic syndromeNaval Daver, Hagop Kantarjian, Guillermo Garcia-Manero, et al.
Pageof 3